Stock listing
SXTP Stock Price, News, Filings & Events — 60 Degrees Pharmaceuticals, Inc.
Selected listing: SXTP · NASDAQ · USD · US
This page tracks 60 Degrees Pharmaceuticals, Inc.'s SXTP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SXTP:NASDAQ. SXTP:NASDAQ is the stock-level entry point for investors researching 60 Degrees Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. 60 Degrees Pharmaceuticals, Inc. is a public company traded under the ticker SXTP in the American market. The company has a market capitalization of approximately $4 million. 60 Degrees Pharmaceuticals focuses on developing innovative therapies for various medical conditions.

- Ticker
- SXTP:NASDAQ
- Asset type
- Stock
- Market cap
- $3.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
60 Degrees Pharmaceuticals, Inc. SXTP:NASDAQ stock context
This page tracks 60 Degrees Pharmaceuticals, Inc.'s SXTP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SXTP:NASDAQ. SXTP:NASDAQ is the stock-level entry point for investors researching 60 Degrees Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. 60 Degrees Pharmaceuticals, Inc. is a public company traded under the ticker SXTP in the American market. The company has a market capitalization of approximately $4 million. 60 Degrees Pharmaceuticals focuses on developing innovative therapies for various medical conditions.
Latest news from 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
August 17, 2026
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
July 30, 2026
60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by Octobe...
July 29, 2026
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne D...
July 8, 2026
Research 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for SXTP:NASDAQ.
60 Degrees Pharmaceuticals, Inc. company profile
View the public company page for 60 Degrees Pharmaceuticals, Inc. on 6ix.
60 Degrees Pharmaceuticals, Inc. news
Read company news and market updates connected to 60 Degrees Pharmaceuticals, Inc..
60 Degrees Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for 60 Degrees Pharmaceuticals, Inc..